Kezar Life Sciences, Inc. (KZR)

NASDAQ: KZR · Real-Time Price · USD

6.25

0.00 (0.00%)

At close: Dec 5, 2025, 4:00 PM EST

6.26

+0.01 (0.16%)

After-hours: Dec 5, 2025, 4:00 PM EST

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
Immune-mediated Diseases and Cancer Therapeutics	7.00M

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
United States	7.00M